Animal Models for Heart Transplantation Focusing on the Pathological Conditions

Cardiac transplant recipients face many complications due to transplant rejection. Scientists must conduct animal experiments to study disease onset mechanisms and develop countermeasures. Therefore, many animal models have been developed for research topics including immunopathology of graft rejection, immunosuppressive therapies, anastomotic techniques, and graft preservation techniques. Small experimental animals include rodents, rabbits, and guinea pigs. They have a high metabolic rate, high reproductive rate, small size for easy handling, and low cost. Additionally, they have genetically modified strains for pathological mechanisms research; however, there is a lacuna, as these research results rarely translate directly to clinical applications. Large animals, including canines, pigs, and non-human primates, have anatomical structures and physiological states that are similar to those of humans; therefore, they are often used to validate the results obtained from small animal studies and directly speculate on the feasibility of applying these results in clinical practice. Before 2023, PubMed Central® at the United States National Institute of Health’s National Library of Medicine was used for literature searches on the animal models for heart transplantation focusing on the pathological conditions. Unpublished reports and abstracts from conferences were excluded from this review article. We discussed the applications of small- and large-animal models in heart transplantation-related studies. This review article aimed to provide researchers with a complete understanding of animal models for heart transplantation by focusing on the pathological conditions created by each model.

[1]  B. Griffith,et al.  Genetically Modified Porcine-to-Human Cardiac Xenotransplantation. , 2022, The New England journal of medicine.

[2]  D. Maluf,et al.  Xenotransplantation: A New Era , 2022, Frontiers in Immunology.

[3]  J. Boeke,et al.  Results of Two Cases of Pig-to-Human Kidney Xenotransplantation. , 2022, The New England journal of medicine.

[4]  Chi-Yuan Li,et al.  Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy , 2022, Biomedicines.

[5]  R. Blasczyk,et al.  Animal Models in Allogenic Solid Organ Transplantation , 2021, Transplantology.

[6]  Chi-Yuan Li,et al.  Transferring Plasmon Effect on a Biological System: Expression of Biological Polymers in Chronic Rejection and Inflammatory Rat Model , 2021, Polymers.

[7]  M. Zembala,et al.  A modified heterotopic heart transplantation in the rat – as an important model in experimental regeneration and replacement of the failing organ , 2020, Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery.

[8]  Chi-Yuan Li,et al.  Dipeptidyl Peptidase-4 Inhibitor Decreases Allograft Vasculopathy Via Regulating the Functions of Endothelial Progenitor Cells in Normoglycemic Rats , 2020, Cardiovascular Drugs and Therapy.

[9]  B. Wong,et al.  Combined abdominal heterotopic heart and aorta transplant model in mice , 2020, bioRxiv.

[10]  M. Netea,et al.  Trained immunity in organ transplantation , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  V. Rao,et al.  A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation. , 2019, Journal of visualized experiments : JoVE.

[12]  D. Cooper Experimental Pig Heart Xenotransplantation-Recent Progress and Remaining Problems. , 2019, The Annals of thoracic surgery.

[13]  J. Ochando,et al.  The innate immune response to allotransplants: mechanisms and therapeutic potentials , 2019, Cellular & Molecular Immunology.

[14]  E. Wolf,et al.  Consistent success in life-supporting porcine cardiac xenotransplantation , 2018, Nature.

[15]  F. Ginhoux,et al.  Inhibiting Inflammation with Myeloid Cell‐Specific Nanobiologics Promotes Organ Transplant Acceptance , 2018, Immunity.

[16]  A. Kissenpfennig,et al.  Development of transplant immunosuppressive agents – considerations in the use of animal models , 2018, Expert opinion on drug discovery.

[17]  Sunil V. Rao,et al.  Cardiac allograft vasculopathy: A review , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[18]  A. Loupy,et al.  Antibody-Mediated Rejection of Solid-Organ Allografts. , 2018, The New England journal of medicine.

[19]  D. Cooper,et al.  Overcoming Coagulation Dysregulation in Pig Solid Organ Transplantation in Nonhuman Primates: Recent Progress. , 2018, Transplantation.

[20]  Xiaoshun He,et al.  Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  F. Ginhoux,et al.  Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  D. Segev,et al.  Antibody‐mediated rejection: New approaches in prevention and management , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  K. Wood,et al.  Regulatory T cells for tolerance. , 2017, Human immunology.

[24]  C. Shun,et al.  CXCR4 Antagonist Reduced the Incidence of Acute Rejection and Controlled Cardiac Allograft Vasculopathy in a Swine Heart Transplant Model Receiving a Mycophenolate-based Immunosuppressive Regimen , 2017, Transplantation.

[25]  Deepak L. Bhatt,et al.  Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation. , 2016, Journal of the American College of Cardiology.

[26]  D. Cooper,et al.  Heart Xenotransplantation: Historical Background, Experimental Progress, and Clinical Prospects. , 2016, The Annals of thoracic surgery.

[27]  D. Roelen,et al.  T-cell alloreactivity and transplantation outcome: a budding role for heterologous immunity? , 2015, Current opinion in organ transplantation.

[28]  A. Kissenpfennig,et al.  The utility of animal models in developing immunosuppressive agents. , 2015, European journal of pharmacology.

[29]  W. Baldwin,et al.  Experimental models of cardiac transplantation: design determines relevance. , 2014, Current opinion in organ transplantation.

[30]  D. Cooper,et al.  Progress in pig‐to‐non‐human primate transplantation models (1998–2013): a comprehensive review of the literature , 2014, Xenotransplantation.

[31]  Marvin L. Thomas,et al.  Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation. , 2014, The Journal of thoracic and cardiovascular surgery.

[32]  J. Chapman,et al.  The Role of Macrophages in the Development of Human Renal Allograft Fibrosis in the First Year After Transplantation , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  Deepali V. Sawant,et al.  Once a Treg, always a Treg? , 2014, Immunological reviews.

[34]  R. F. Hoyt,et al.  One‐Year Heterotopic Cardiac Xenograft Survival in a Pig to Baboon Model , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[35]  Michelle L. Miller,et al.  Lessons and limits of mouse models. , 2013, Cold Spring Harbor perspectives in medicine.

[36]  J. Kupiec-Weglinski,et al.  The innate immune system and transplantation. , 2013, Cold Spring Harbor perspectives in medicine.

[37]  D. Green,et al.  Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury , 2013, Proceedings of the National Academy of Sciences.

[38]  Kebin Liu,et al.  Hmgb1-TLR4-IL-23-IL-17A Axis Promote Ischemia-Reperfusion Injury in a Cardiac Transplantation Model , 2013, Transplantation.

[39]  James A. Hutchinson,et al.  IFN-γ-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  E. Reed,et al.  Blockade of P‐Selectin Is Sufficient to Reduce MHC I Antibody‐Elicited Monocyte Recruitment In Vitro and In Vivo , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[41]  K. Wood,et al.  Homing of Regulatory T Cells to Human Skin Is Important for the Prevention of Alloimmune-Mediated Pathology in an In Vivo Cellular Therapy Model , 2012, PloS one.

[42]  S. Knechtle,et al.  Patterns of De Novo Allo B Cells and Antibody Formation in Chronic Cardiac Allograft Rejection After Alemtuzumab Treatment , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[43]  R. Fairchild,et al.  Antibody‐Mediated Rejection of Single Class I MHC‐Disparate Cardiac Allografts , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[44]  C. McGregor,et al.  Cardiac xenotransplantation: progress and challenges , 2012, Current opinion in organ transplantation.

[45]  W. Chapman,et al.  Mechanism of Accommodation in a Sensitized Human Leukocyte Antigen Transgenic Murine Cardiac Transplant Model , 2012, Transplantation.

[46]  R. Mannon Macrophages: contributors to allograft dysfunction, repair, or innocent bystanders? , 2012, Current opinion in organ transplantation.

[47]  R. Colvin,et al.  A Novel Pathway of Chronic Allograft Rejection Mediated by NK Cells and Alloantibody , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[48]  S. Knechtle,et al.  Primary Vascularization of the Graft Determines the Immunodominance of Murine Minor H Antigens during Organ Transplantation , 2011, The Journal of Immunology.

[49]  M. Fishbein,et al.  Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[50]  S. Akira,et al.  Epigenetic control of macrophage polarization , 2011, European journal of immunology.

[51]  X. Jouven,et al.  Very Late Heart Transplant Rejection Is Associated with Microvascular Injury, Complement Deposition and Progression to Cardiac Allograft Vasculopathy , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[52]  R. Lechler,et al.  Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells , 2011, Science Translational Medicine.

[53]  N. Samani,et al.  Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury , 2011, Proceedings of the National Academy of Sciences.

[54]  S. Robson,et al.  Controlling coagulation dysregulation in xenotransplantation , 2011, Current opinion in organ transplantation.

[55]  A. Chong,et al.  Alloantibodies Prevent the Induction of Transplantation Tolerance by Enhancing Alloreactive T Cell Priming , 2011, The Journal of Immunology.

[56]  L. Riella,et al.  Animal Models of Chronic Allograft Injury: Contributions and Limitations to Understanding the Mechanism of Long-Term Graft Dysfunction , 2010, Transplantation.

[57]  W. Baldwin,et al.  Cardiac allograft vasculopathy: do adipocytes bridge alloimmune and metabolic risk factors? , 2010, Current opinion in organ transplantation.

[58]  S. Akira,et al.  A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release , 2010, Proceedings of the National Academy of Sciences.

[59]  K. Wood,et al.  In vivo Prevention of Transplant Arteriosclerosis by ex vivo Expanded Human Regulatory T Cells , 2010, Nature Medicine.

[60]  P. Dellapelle,et al.  Complement Independent Antibody‐Mediated Endarteritis and Transplant Arteriopathy in Mice , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[61]  P. Doevendans,et al.  Myocardial Ischemia / Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti – Toll-Like Receptor-2 Antibody , 2009 .

[62]  W. Baldwin,et al.  Immunological Challenges of Cardiac Transplantation: The need for Better Animal Models to Answer Current Clinical Questions , 2009, Journal of Clinical Immunology.

[63]  Yanping Hu,et al.  Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model , 2009, Immunology.

[64]  V. Rao,et al.  Donor Pretreatment With Hypertonic Saline Attenuates Primary Allograft Dysfunction: A Pilot Study in a Porcine Model , 2009, Circulation.

[65]  G. Opelz,et al.  Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study. , 2009, Human immunology.

[66]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[67]  A. Valujskikh,et al.  Effector Functions of Donor‐Reactive CD8 Memory T Cells Are Dependent on ICOS Induced During Division in Cardiac Grafts , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[68]  P. Heeger,et al.  Donor Deficiency of Decay-Accelerating Factor Accelerates Murine T Cell-Mediated Cardiac Allograft Rejection1 , 2008, The Journal of Immunology.

[69]  A. Valujskikh,et al.  Donor‐Reactive CD8 Memory T Cells Infiltrate Cardiac Allografts Within 24‐h Posttransplant in Naive Recipients , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[70]  P. Lake,et al.  Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[71]  F. Gao,et al.  Anti-MHC Class I Antibody Activation of Proliferation and Survival Signaling in Murine Cardiac Allografts1 , 2008, The Journal of Immunology.

[72]  A. Chong,et al.  Hyperacute Rejection by Anti-Gal IgG1, IgG2a, and IgG2b Is Dependent on Complement and Fc-γ Receptors1 , 2008, The Journal of Immunology.

[73]  J. Madsen,et al.  Macrophage Depletion Suppresses Cardiac Allograft Vasculopathy in Mice , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[74]  A. Chong,et al.  Expression of Complement Regulatory Proteins in Accommodated Xenografts Induced by Anti‐α‐Gal IgG1 in a Rat‐to‐Mouse Model , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[75]  W. Baldwin,et al.  Synergistic Deposition of C4d by Complement‐Activating and Non‐activating Antibodies in Cardiac Transplants , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[76]  C. Orosz,et al.  Antibody-Mediated Rejection of Cardiac Allografts in CCR5-Deficient Recipients1 , 2007, The Journal of Immunology.

[77]  B. Huang,et al.  Extracellular Hmgb1 Functions as an Innate Immune‐Mediator Implicated in Murine Cardiac Allograft Acute Rejection , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[78]  P. Terasaki,et al.  Four‐year Follow‐up of a Prospective Trial of HLA and MICA Antibodies on Kidney Graft Survival , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[79]  R. Colvin,et al.  Chronic Cardiac Transplant Arteriopathy in Mice: Relationship of Alloantibody, C4d Deposition and Neointimal Fibrosis , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[80]  M. Sykes,et al.  Decay-Accelerating Factor Prevents Acute Humoral Rejection Induced by Low Levels of Anti-αGal Natural Antibodies , 2006, Transplantation.

[81]  V. Rao,et al.  Cardiac allograft preservation using donor-shed blood supplemented with L-arginine. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[82]  Keiji Oi,et al.  Cardiac xenotransplantation : Recent preclinical progress with 3-month median survival , 2005 .

[83]  R. Colvin,et al.  NK Cells Can Trigger Allograft Vasculopathy: The Role of Hybrid Resistance in Solid Organ Allografts1 , 2005, The Journal of Immunology.

[84]  R. Strieter,et al.  Inhibition of Polymorphonuclear Leukocyte–Mediated Graft Damage Synergizes With Short-Term Costimulatory Blockade to Prevent Cardiac Allograft Rejection , 2005, Circulation.

[85]  S. Keshavjee,et al.  Innate Immunity and Organ Transplantation: The Potential Role of Toll‐like Receptors , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[86]  S. Schenk,et al.  Alloreactive T Cell Responses and Acute Rejection of Single Class II MHC-Disparate Heart Allografts Are under Strict Regulation by CD4+CD25+ T Cells1 , 2005, The Journal of Immunology.

[87]  K. Kuwaki,et al.  Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons , 2004, Xenotransplantation.

[88]  B. Tesar,et al.  TH1 Immune Responses to Fully MHC Mismatched Allografts are Diminished in the Absence of MyD88, a Toll‐Like Receptor Signal Adaptor Protein , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[89]  A. Sharpe,et al.  Mechanism of action of donor-specific transfusion in inducing tolerance: role of donor MHC molecules, donor co-stimulatory molecules, and indirect antigen presentation. , 2004, Journal of the American Society of Nephrology : JASN.

[90]  A. Chong,et al.  Cutting Edge: NK Cells Mediate IgG1-Dependent Hyperacute Rejection of Xenografts1 , 2004, The Journal of Immunology.

[91]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[92]  W. Baldwin,et al.  Non‐Complement‐ and Complement‐Activating Antibodies Synergize to Cause Rejection of Cardiac Allografts , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[93]  S. Schenk,et al.  Effects of T Cell Frequency and Graft Size on Transplant Outcome in Mice 1 , 2004, The Journal of Immunology.

[94]  Egil Lien,et al.  Injury Primes the Innate Immune System for Enhanced Toll-Like Receptor Reactivity1 , 2003, The Journal of Immunology.

[95]  H. Spotnitz,et al.  Aortic regurgitation in the heterotopic rat heart transplant: effect on ventricular remodeling and diastolic function. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[96]  D. Harlan,et al.  RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52‐SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH‐1H) , 2003, Transplantation.

[97]  S. Akira,et al.  Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. , 2003, The Journal of clinical investigation.

[98]  P. Dyer,et al.  Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1 , 2003, Transplantation.

[99]  T. Strom,et al.  Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size1 , 2002, The Journal of Immunology.

[100]  M. Fishbein,et al.  The role of MIG/CXCL9 in cardiac allograft vasculopathy. , 2002, The American journal of pathology.

[101]  C. Hemenway,et al.  Cellular protein binds to sequences near the 5' terminus of potato virus X RNA that are important for virus replication. , 2002, Virology.

[102]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[103]  Charles A. Janeway,et al.  Decoding the Patterns of Self and Nonself by the Innate Immune System , 2002, Science.

[104]  W. Land,et al.  Postischemic Reperfusion Injury to Allografts – A Case for ‘Innate Immunity’? , 2002, European Surgical Research.

[105]  M. Karim,et al.  CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses1 , 2002, The Journal of Immunology.

[106]  M. Niimi,et al.  The technique for heterotopic cardiac transplantation in mice: experience of 3000 operations by one surgeon. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[107]  Michael C. Montalto,et al.  Inhibition of Mannose-Binding Lectin Reduces Postischemic Myocardial Reperfusion Injury , 2001, Circulation.

[108]  S. Akira,et al.  Toll-like receptors control activation of adaptive immune responses , 2001, Nature Immunology.

[109]  K. Wood,et al.  Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[110]  M. Pearse,et al.  Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout mice , 2000, Xenotransplantation.

[111]  K. Abe,et al.  In situ localization of C3 synthesis in experimental acute renal allograft rejection. , 2000, The American journal of pathology.

[112]  A. D. McLean,et al.  Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection. , 2000, Transplantation.

[113]  D. Sachs,et al.  High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. , 2000, Transplantation.

[114]  C. Tannenbaum,et al.  Intraallograft Chemokine RNA and Protein During Rejection of MHC-Matched/Multiple Minor Histocompatibility-Disparate Skin Grafts1 , 2000, The Journal of Immunology.

[115]  D. Adams,et al.  Heterotopic heart transplantation: experimental development and clinical experience. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[116]  A. Novick,et al.  T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig. , 1999, Journal of immunology.

[117]  D. Adams,et al.  Technique for heterotopic pig heart xenotransplantation in primates. , 1999, The Annals of thoracic surgery.

[118]  L. Turka,et al.  Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes , 1998, Nature Medicine.

[119]  E. Witort,et al.  Anti-Gal antibody-mediated allograft rejection in alpha1,3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejection. , 1998, Transplantation.

[120]  I. Konstantinov A mystery of Vladimir P. Demikhov: the 50th anniversary of the first intrathoracic transplantation. , 1998, The Annals of thoracic surgery.

[121]  P. Russell,et al.  Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice. , 1997, Transplantation.

[122]  D. Sachs,et al.  Species differences in the expression of major histocompatibility complex class II antigens on coronary artery endothelium: implications for cell-mediated xenoreactivity. , 1997, Transplantation.

[123]  R. Levine,et al.  A new, biventricular working heterotopic heart transplant model: anatomic and physiologic considerations. , 1997, Transplantation.

[124]  R. Weisel,et al.  Donor blood perfusion improves myocardial recovery after heart transplantation. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[125]  P. Linsley,et al.  Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[126]  D. White,et al.  The generation of transgenic pigs as potential organ donors for humans , 1995, Nature Medicine.

[127]  H. Winn,et al.  Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. , 1994, Journal of immunology.

[128]  H. Mohri,et al.  Hemodynamic performance in a heterotopically transplanted dog heart: proposal of techniques for working left heart model of heterotopic (abdominal) heart transplantation. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[129]  I. Klein,et al.  Isovolumic loading prevents atrophy of the heterotopically transplanted rat heart. , 1991, Circulation research.

[130]  I. Klein,et al.  Cardiac atrophy in the heterotopically transplanted rat heart: in vitro protein synthesis. , 1990, Journal of molecular and cellular cardiology.

[131]  R. Michler,et al.  Technique for Primate Heterotopic Cardiac Xenotransplantation , 1985, Journal of medical primatology.

[132]  H. Mcdevitt,et al.  Gene conversion between murine class II major histocompatibility complex loci. Functional and molecular evidence from the bm 12 mutant , 1984, The Journal of experimental medicine.

[133]  S. Fuggle,et al.  THE DETAILED DISTRIBUTION OF MHC CLASS II ANTIGENS IN NORMAL HUMAN ORGANS , 1984, Transplantation.

[134]  S. Jamieson,et al.  A new method for heterotopic cardiac transplantation in the dog. , 1982, The Journal of surgical research.

[135]  S. Papson,et al.  “Model” , 1981 .

[136]  M. Sandrin,et al.  B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse , 1979, The Journal of experimental medicine.

[137]  Donor pretreatment. , 1977, British medical journal.

[138]  J. Losman,et al.  Hemodynamic evaluation of left ventricular bypass with a homologous cardiac graft. , 1977, The Journal of thoracic and cardiovascular surgery.

[139]  R. Corry,et al.  PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICE: THE ROLE OF H‐2D, H‐2K, AND NON‐H-2 ANTIGENS IN REJECTION , 1973, Transplantation.

[140]  K Ono,et al.  Improved technique of heart transplantation in rats. , 1969, The Journal of thoracic and cardiovascular surgery.

[141]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.

[142]  N. Mueller,et al.  Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience , 2005, Nature Medicine.

[143]  T. Starzl,et al.  Improved surgical technique for the establishment of a murine model of aortic transplantation , 1998, Microsurgery.

[144]  R. Michler,et al.  Modified technique for heterotopic heart transplantation in small primates. , 1997, The Annals of thoracic surgery.